The current valuation score of Collegium Pharmaceutical Inc is 8.50, ranking 84 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 14.22, which is 734.15% below the recent high of 118.62 and 621.15% above the recent low of -74.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.